Literature DB >> 15234530

Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications.

Sergio Rutella1, Roberto M Lemoli.   

Abstract

The induction of antigen (Ag)-specific tolerance is critical for the prevention of autoimmunity and maintenance of immune homeostasis. Recently, attention has been focused on induction of active suppression by regulatory T cells (Treg cells). Also, a role for dendritic cells (DCs) in the promotion of peripheral tolerance has been demonstrated by several studies and is the subject of intensive investigation. It is currently believed that the maturation/activation state of DCs might be a control point for the induction of peripheral tolerance through modifications of the activation state of T cells. Several lines of experimental evidence suggest that unique DC subsets or discrete functional states of the DCs might be devoted to the promotion of Treg cell differentiation. The present review summarizes the emerging literature on the developmental origin and function of human Treg cells and tolerogenic/regulatory DCs. Furthermore, clinical implications of these studies for cellular therapy of immune-mediated pathologies are discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15234530     DOI: 10.1016/j.imlet.2004.04.015

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  35 in total

1.  Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

Authors:  Alejo Chorny; Elena Gonzalez-Rey; Amelia Fernandez-Martin; David Pozo; Doina Ganea; Mario Delgado
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

2.  Role of dendritic cells in progression and clinical outcome of colon cancer.

Authors:  Maya V Gulubova; Julian R Ananiev; Tatyana I Vlaykova; Yovcho Yovchev; Vanya Tsoneva; Irena M Manolova
Journal:  Int J Colorectal Dis       Date:  2011-11-09       Impact factor: 2.571

3.  Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.

Authors:  Elena Gonzalez-Rey; Alejo Chorny; Amelia Fernandez-Martin; Doina Ganea; Mario Delgado
Journal:  Blood       Date:  2006-01-05       Impact factor: 22.113

Review 4.  Immunopathogenesis of IBD: insufficient suppressor function in the gut?

Authors:  I L Huibregtse; A U van Lent; S J H van Deventer
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

5.  CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients.

Authors:  Sean M Studer; M Patricia George; Xuehai Zhu; Yifang Song; Vincent G Valentine; Michael W Stoner; Jigme Sethi; Chad Steele; Steven R Duncan
Journal:  Am J Respir Crit Care Med       Date:  2008-07-10       Impact factor: 21.405

6.  Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response.

Authors:  Alejo Chorny; Elena Gonzalez-Rey; Amelia Fernandez-Martin; Doina Ganea; Mario Delgado
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

7.  Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis.

Authors:  Matthew N Meriggioli; Jian Rong Sheng; Liangcheng Li; Bellur S Prabhakar
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

8.  CD40-activated B cells are more potent than immature dendritic cells to induce and expand CD4(+) regulatory T cells.

Authors:  Jian Zheng; Yinping Liu; Yu-Lung Lau; Wenwei Tu
Journal:  Cell Mol Immunol       Date:  2010-01       Impact factor: 11.530

9.  Prevalence of Foxp3 positive T regulatory cells is increased during progression of cutaneous squamous tumors.

Authors:  Tae Jung Jang
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

Review 10.  Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?

Authors:  Leigh R Guerin; Jelmer R Prins; Sarah A Robertson
Journal:  Hum Reprod Update       Date:  2009-03-11       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.